Prosecution Insights
Last updated: October 02, 2026

Singular Genomics Systems Inc.

Technology area: Biotechnology & Pharmaceuticals

26 pending office actions • 10 art units • 22 examiners • 0 of 26 (0%) have an AI response strategy ready • 28 patents granted in the last 365 days

Analysis

Singular Genomics Systems Inc. currently manages 26 pending office actions within the Biotechnology & Pharmaceuticals technology area. This workload is distributed across 10 distinct art units, indicating a diverse range of technical subject matter within the portfolio. The company interacts with 22 distinct examiners, suggesting that prosecution strategies must be tailored to a variety of individual preferences and styles across the patent office.

The busiest examiner for this portfolio is LU, FRANK WEI MIN, who is responsible for 3 pending office actions. While the portfolio spans 10 distinct art units, the concentration of work under a single examiner represents a specific point of focus for the company's legal team. Managing 26 pending office actions across 22 distinct examiners requires a broad approach to patent prosecution to ensure consistency. This volume of filings highlights an active phase of intellectual property development for the firm.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

26
Total Pending OAs
18
Non-Final OAs
8
Final Rejections
0
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 5 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

3
Overdue
0
Due this week
2
Due this month
0
Due in next 60 days
0
Due later

Deadline Fire Line

Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 5 of the docket's apps have a known mailing date.

-30dToday30d60d90d120d
Overdue (3)Due ≤ 30 days (2)

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

13
Hard (50%)
9
Medium (35%)
4
Easy (15%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§103 only6 (23%)
§112 only4 (15%)
Double-patenting + other3 (12%)
Multi-statute (no §101)13 (50%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

21
Life Sciences
81% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
0
Mechanical / Eng
0% of docket
5
Business / Other
19% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

260 h
Manual time on pending OAs
52 h
Time saved (low, 20%)
91 h
Time saved (mid, 35%)
2.3 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
LU, FRANK WEI MIN 3 62.7% +67.7%
YU, TIAN NMN 2 55.1% +20.4%
KIM, YOUNG J 2 64.8% +18.1%
QIAN, CELINE X 1 47.6% +16.9%
ELHILO, EISA B 1 83.0% +16.2%
HERON, VELVET ELIZABETH 1 47.4% +52.6%
HAQ, SHAFIQUL 1 64.8% +55.2%
SISSON, BRADLEY L 1 19.7% +20.5%
WILDER, CYNTHIA B 1 71.0% +26.6%
MUMMERT, STEPHANIE KANE 1 61.2% +21.4%

Hard Cases (14)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
18050688 METHODS AND COMPOSITIONS USEFUL FOR NUCLEIC ACID SEQUENCING CROW, ROBERT THOMAS 97d overdue
18364849 COMPETITIVE METHODS AND COMPOSITIONS FOR AMPLIFYING POLYNUCLEOTIDES TURPIN, ZACHARY MARK 8d overdue
17938254 Polynucleotide Barcodes for Multiplexed Proteomics BUNKER, AMY M 4d overdue
18915941 PROXIMITY DETECTION OF BIOMOLECULE INTERACTIONS SISSON, BRADLEY L 13d
18537266 CONTROLLED ROLLING CIRCLE AMPLIFICATION KIM, YOUNG J 27d
19345390 ENCODING METHODS FOR MULTIPLEXED DETECTION OF TARGETS IN CELLS QIAN, CELINE X —
19228533 RHODAMINE FLUORESCENT COMPOUNDS AND METHODS OF USE THEREOF ELHILO, EISA B —
19038150 SOLID SUPPORTS USEFUL FOR TISSUE ADHERENCE HERON, VELVET ELIZABETH —

Interview Candidates (14)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
18915941 PROXIMITY DETECTION OF BIOMOLECULE INTERACTIONS SISSON, BRADLEY L 13d
18537266 CONTROLLED ROLLING CIRCLE AMPLIFICATION KIM, YOUNG J 27d
19345390 ENCODING METHODS FOR MULTIPLEXED DETECTION OF TARGETS IN CELLS QIAN, CELINE X —
19344246 METHODS FOR THREE-DIMENSIONAL NUCLEIC ACID SEQUENCING LU, FRANK WEI MIN —
19228533 RHODAMINE FLUORESCENT COMPOUNDS AND METHODS OF USE THEREOF ELHILO, EISA B —
19038150 SOLID SUPPORTS USEFUL FOR TISSUE ADHERENCE HERON, VELVET ELIZABETH —
18959243 ANALYZING CELL SAMPLES HAQ, SHAFIQUL —
18812056 METHODS AND COMPOSITIONS FOR REDUCING NUCLEOTIDE IMPURITIES WILDER, CYNTHIA B —

Top Art Units

Art UnitApps
1681 6
1682 5
1683 3
1637 1
1798 1
1678 1
1693 1
1699 1
1677 1
1684 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
19345390 ENCODING METHODS FOR MULTIPLEXED DETECTION OF TARGETS IN CELLS QIAN, CELINE X 1637 §103§112Other Final Rejection — Pending Sep 30, 2025
19344246 METHODS FOR THREE-DIMENSIONAL NUCLEIC ACID SEQUENCING LU, FRANK WEI MIN 1683 §112 Non-Final OA — Pending Sep 29, 2025
19228533 RHODAMINE FLUORESCENT COMPOUNDS AND METHODS OF USE THEREOF ELHILO, EISA B — §102§112 Non-Final OA — Pending Jun 04, 2025
19038150 SOLID SUPPORTS USEFUL FOR TISSUE ADHERENCE HERON, VELVET ELIZABETH 1798 §102§103 Non-Final OA — Pending Jan 27, 2025
18959243 ANALYZING CELL SAMPLES HAQ, SHAFIQUL 1678 §103§112 Final Rejection — Pending Nov 25, 2024
18915941 PROXIMITY DETECTION OF BIOMOLECULE INTERACTIONS SISSON, BRADLEY L 1682 §112 Non-Final OA 13d Pending Oct 15, 2024
18812056 METHODS AND COMPOSITIONS FOR REDUCING NUCLEOTIDE IMPURITIES WILDER, CYNTHIA B — §112DP Non-Final OA — Pending Aug 22, 2024
18797131 SPATIAL DETECTION OF CLONOTYPES IN TISSUES MUMMERT, STEPHANIE KANE 1681 §102§103 Non-Final OA — Pending Aug 07, 2024
18679036 PHOTOSTABLE DETECTABLE COMPOUNDS XU, XIAOYUN — §103 Non-Final OA — Pending May 30, 2024
18704416 MANIPULATING AND DETECTING BIOLOGICAL SAMPLES YU, TIAN NMN — §102§103§112 Non-Final OA — Pending Apr 24, 2024
18592127 METHODS FOR DIFFERENTIATING MODIFIED NUCLEOBASES PRIEST, AARON A — §103 Non-Final OA — Pending Feb 29, 2024
18390463 TARGETING OLIGONUCLEOTIDES AND METHODS OF USE THEREOF KIM, YOUNG J 1681 §103§112 Non-Final OA — Pending Dec 20, 2023
18543979 DISULFIDE CONTAINING THERAPEUTICS GALSTER, SAMUEL LEONARD 1693 §103 Non-Final OA — Pending Dec 18, 2023
18537266 CONTROLLED ROLLING CIRCLE AMPLIFICATION KIM, YOUNG J 1681 §102§103§112 Final Rejection 27d Pending Dec 12, 2023
18537540 LINKED TRANSCRIPT SEQUENCING GOLDBERG, JEANINE ANNE 1682 §103DP Non-Final OA — Pending Dec 12, 2023
18507761 AMPLIFICATION OLIGONUCLEOTIDES GREENE, CAROLYN LEE 1681 §103§112 Final Rejection — Pending Nov 13, 2023
18490491 MULTI-DIMENSIONAL POLYMER SCAFFOLDS FOR NUCLEIC ACID ANALYSES WHATLEY, BENJAMIN R 1699 §102§103§112DP Non-Final OA — Pending Oct 19, 2023
18365476 TETHERED DETECTION ASSAYS EVANS, CHRISTOPHER RYAN 1677 §102§103§112 Non-Final OA — Pending Aug 04, 2023
18364849 COMPETITIVE METHODS AND COMPOSITIONS FOR AMPLIFYING POLYNUCLEOTIDES TURPIN, ZACHARY MARK 1682 §103§112 Final Rejection 8d overdue Pending Aug 03, 2023
18303468 TARGETED SEQUENCING HORLICK, KENNETH R 1681 §103 Final Rejection — Pending Apr 19, 2023
18069990 STRAND DISPLACING SEQUENCING ENZYMES LU, FRANK WEI MIN 1683 §112 Non-Final OA — Pending Dec 21, 2022
18069078 PHASE PROTECTIVE REAGENT FLOW ORDERING KENNEDY, SARAH JANE 1682 §103 Final Rejection — Pending Dec 20, 2022
18050688 METHODS AND COMPOSITIONS USEFUL FOR NUCLEIC ACID SEQUENCING CROW, ROBERT THOMAS 1682 §103§112 Non-Final OA 97d overdue Pending Oct 28, 2022
17938254 Polynucleotide Barcodes for Multiplexed Proteomics BUNKER, AMY M 1684 §102§103 Final Rejection 4d overdue Pending Oct 05, 2022
17938329 METHODS FOR IN SITU PROTEOMICS LU, FRANK WEI MIN 1683 §112 Non-Final OA — Pending Oct 05, 2022
17531488 CONTACTLESS DETECTION OF AN ABERRANT CONDITION YU, TIAN NMN 1681 §103 Non-Final OA — Pending Nov 19, 2021

Managing Singular Genomics Systems Inc.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month